UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Intestinal lymphatic transport for drug delivery

Advanced drug delivery reviews, 2011-09, Vol.63 (10), p.923-942

2011

Link zum Volltext

Verfügbarkeit prüfen

Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure–Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program

Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1818-1829

2016

Link zum Volltext

Verfügbarkeit prüfen

An orally available non-nucleotide STING agonist with antitumor activity

Science (American Association for the Advancement of Science), 2020-08, Vol.369 (6506)

2020

Link zum Volltext

Verfügbarkeit prüfen

A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery

Drug metabolism and disposition, 2020-11, Vol.48 (11), p.1147-1160

2020

Link zum Volltext

Verfügbarkeit prüfen

In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin

Cell chemical biology, 2023-11, Vol.30 (11), p.1468-1477.e6

2023

Link zum Volltext

Verfügbarkeit prüfen

Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline

Toxicological sciences, 2020-09, Vol.177 (1), p.121-139

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold

Bioorganic & medicinal chemistry letters, 2021-10, Vol.49, p.128314-128314, Article 128314

2021

Link zum Volltext

Verfügbarkeit prüfen

Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue

Rapid communications in mass spectrometry, 2006-03, Vol.20 (6), p.965-972

2006

Link zum Volltext

Verfügbarkeit prüfen

Vicriviroc (SCH 417690) Distribution from the Gut to Gut-Associated Lymphoid Tissues (GALT) and to Peripheral Lymphoid Tissues Following an Oral Dose

Retrovirology, 2005-12, Vol.2 (S1), p.P115-P115, Article P115

2005

Link zum Volltext

Verfügbarkeit prüfen

STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors

Molecular cancer therapeutics, 2022-02, Vol.21 (2), p.282-293

2022

Link zum Volltext

Verfügbarkeit prüfen

Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes

Bioorganic & medicinal chemistry letters, 2020-09, Vol.30 (17), p.127390-127390, Article 127390

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

ACS medicinal chemistry letters, 2019-11, Vol.10 (11), p.1530-1536

2019

Link zum Volltext

Verfügbarkeit prüfen

SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors

Bioorganic & medicinal chemistry letters, 2021-09, Vol.47, p.128214-128214, Article 128214

2021

Link zum Volltext

Verfügbarkeit prüfen

Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase‑1 (IDO1)

ACS medicinal chemistry letters, 2020-04, Vol.11 (4), p.550-557

2020

Link zum Volltext

Verfügbarkeit prüfen

Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors

ACS medicinal chemistry letters, 2021-09, Vol.12 (9), p.1435-1440

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4721: Combining STING agonists with an anti-PD-1 antagonist results in marked antitumor activity in immune-excluded tumors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4721-4721

2018

Link zum Volltext

Verfügbarkeit prüfen

Carbamate and N‑Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors

ACS medicinal chemistry letters, 2021-03, Vol.12 (3), p.389-396

2021

Link zum Volltext

Verfügbarkeit prüfen

Discovery of novel BTK inhibitors with carboxylic acids

Bioorganic & medicinal chemistry letters, 2017-03, Vol.27 (6), p.1471-1477

2017

Link zum Volltext

Verfügbarkeit prüfen

Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors

ACS medicinal chemistry letters, 2022-04, Vol.13 (4), p.734-741

2022

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis

Bioorganic & medicinal chemistry letters, 2017-08, Vol.27 (16), p.3939-3943

2017

Link zum Volltext

Verfügbarkeit prüfen

Qualification and application of an in vitro liver model early in pharmaceutical development to help derisk drug-induced liver injury (DILI)

Drug metabolism and pharmacokinetics, 2019-01, Vol.34 (1), p.S42-S42

2019

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension

ACS medicinal chemistry letters, 2017-01, Vol.8 (1), p.128-132

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Pharmacology & Pharmacy
(16)
Animals
(13)
Chemistry, Medicinal
(12)
Humans
(10)
Chemistry
(7)
Letter
(7)
Physical Sciences
(7)
Rats
(7)
Chemistry, Organic
(5)
Ido1
(4)
Male
(4)
Mice
(4)
Structure-Activity Relationship
(4)
Dose-Response Relationship, Drug
(3)
Indoleamine-Pyrrole 2,3,-Dioxygenase - Metabolism
(3)
Kinase Selectivity
(3)
Molecular Structure
(3)
60 Applied Life Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Intestinal lymphatic transport for drug delivery

Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure–Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program

An orally available non-nucleotide STING agonist with antitumor activity

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery

In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin

Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline

Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold

Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue

Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing

Vicriviroc (SCH 417690) Distribution from the Gut to Gut-Associated Lymphoid Tissues (GALT) and to Peripheral Lymphoid Tissues Following an Oral Dose

STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors

Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes

Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors

Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase‑1 (IDO1)

Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors

Abstract 4721: Combining STING agonists with an anti-PD-1 antagonist results in marked antitumor activity in immune-excluded tumors

Carbamate and N‑Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors

Discovery of novel BTK inhibitors with carboxylic acids

Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors

Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis

Qualification and application of an in vitro liver model early in pharmaceutical development to help derisk drug-induced liver injury (DILI)

Discovery of 8‑Amino-imidazo[1,5‑a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis

Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension

Suchergebnisse filtern